Nirav Shirish Mody
Fortuna: 7 M $ al 31/05/2026
Fortuna: 7 M $ al 31/05/2026
Nirav Shirish Mody is currently a Director at Biotech Laboratories (Pty) Ltd. Previously, he worked as the President-Global Business & Business Development at J.B. Chemicals & Pharmaceuticals Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Sasken Technologies Ltd.
Sasken Technologies Ltd. Information Technology ServicesTechnology Services Provides software services 1,93 % | 31/12/2024 | 293.610 ( 1,93 % ) | 7 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Biotech Laboratories (Pty) Ltd.
Biotech Laboratories (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and branded pharmaceuticals | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| J. B. CHEMICALS & PHARMACEUTICALS LIMITED | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
J.B. Chemicals & Pharmaceuticals Ltd.
J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals products | Health Technology |
Biotech Laboratories (Pty) Ltd.
Biotech Laboratories (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and branded pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.